 differenti therapi acut promyelocyt leukemia tretinoin all-trans-retino acid background and method patient acut promyelocyt leukemia characterist transloc breakpoint chromosom region retino acid receptor-alpha rar-alpha receptor growth differenti myeloid cell vitro recent clinic studi tretinoin all-trans-retino acid complet remiss patient acut promyelocyt leukemia effect tretinoin cellular matur molecular abnorm patient induct remiss agent result eleven patient acut promyelocyt leukemia tretinoin dose mg squar meter body-surfac area day nine patient complet remiss patient complet remiss leukocytosi continu drug treatment serial studi cellular morpholog featur cell-surfac immunophenotyp analysi fluoresc situ hybrid chromosom probe clinic respons matur leukem clone patient treatment northern blot analysi express aberr rar-alpha patient complet remiss express abnorm rar-alpha messag detect sever patient complet morpholog cytogenet remiss conclus tretinoin safe effect agent complet remiss patient acut promyelocyt leukemia clinic respons agent leukemic-cel differenti express aberr rar-alpha nuclear receptor molecular detect aberr receptor use marker residu leukemia patient diseas